文献速递中毒与环境急症儿科与产科急症重症综合管理与镇静镇痛

急性大麻中毒

Acute cannabis toxicity.
PubMed 文献 · Clin Toxicol (Phila) · 2019-01-24
一句话结论急性大麻暴露后神经毒性常见,儿童多为意外摄入家庭自制食品,浓缩产品与更高的插管和ICU入住风险相关。

该观察性研究分析了俄勒冈州和阿拉斯加州毒物中心2015年12月4日至2017年4月17日期间253例急性大麻暴露者(中位年龄20岁,范围8个月至96岁,54.2%为男性)。儿童(<12岁)多意外摄入家庭自制食品并出现镇静,成人多故意摄入零售食品并出现神经兴奋;青少年介于两者之间。所有年龄段中,吸入暴露后心动过速和神经兴奋较摄入更常见。8例入住ICU,3例插管,1例死亡;浓缩产品更易导致插管,儿童暴露于浓缩产品后ICU入住和插管可能性更高。

要点

  • 急性大麻暴露后神经毒性常见,儿童多表现为镇静,成人多表现为神经兴奋。
  • 儿童暴露98.6%为意外,97.2%为摄入,64.8%涉及食品,73.2%产品属于家庭成员。
  • 成人暴露88.6%为故意,66.4%为摄入,48.6%涉及食品,47.1%出现神经兴奋。
  • 吸入暴露后心动过速和神经兴奋较摄入暴露更常见。
  • 浓缩产品(树脂和液体浓缩物)更易导致插管,儿童暴露后ICU入住和插管可能性更高;8例入住ICU,3例插管,1例死亡。

适用人群与场景

  • 俄勒冈州和阿拉斯加州毒物中心2015年12月4日至2017年4月17日期间报告的急性大麻暴露者,包括儿童(<12岁)、青少年(12-17岁)和成人(≥18岁)。
  • 纳入标准:毒物中心接到关于急性大麻暴露的来电,来电者可为暴露者本人、其家人或朋友,或参与其医疗照护的医疗工作者。
  • 排除标准:无明确暴露、慢性暴露、存在共同摄入物、非人类暴露(如宠物)。

红旗征与不能漏的情况

  • 儿童意外摄入家庭自制食品后出现镇静,需警惕严重结局。
  • 浓缩产品(树脂和液体浓缩物)暴露,尤其摄入途径,与更高的插管风险相关;儿童暴露于浓缩产品后ICU入住和插管可能性更高。
  • 出现神经兴奋或镇静等神经毒性表现。

研究设计与关键结果

  • 观察性研究,纳入253例急性大麻暴露者(中位年龄20岁,范围8个月至96岁,54.2%为男性):71例(28.1%)儿童(<12岁),42例(16.6%)青少年(12-17岁),140例(55.3%)成人(≥18岁)。
  • 儿童最常意外暴露(98.6%),摄入途径(97.2%),家庭自制食品(35.2%),食品类产品(64.8%),产品属于家庭成员(73.2%),出现镇静(52.1%)。
  • 成人最常故意暴露(88.6%),摄入途径(66.4%),零售产品(40.0%),食品类产品(48.6%),出现神经兴奋(47.1%)。
  • 青少年最常故意暴露(81.0%),摄入途径(50.0%),家庭自制产品(23.8%),食品类产品(45.2%),产品属于朋友(47.3%),出现神经兴奋(42.9%)或镇静(40.5%)。
  • 所有年龄段中,吸入暴露后心动过速和神经兴奋较摄入暴露更常见。
  • 8例入住ICU,包括3例插管,1例死亡;食品类产品是所有年龄组中最常引起症状的产品,浓缩产品更易导致插管,尤其摄入途径;儿童暴露于浓缩产品后ICU入住和插管可能性更高。

证据类型、等级与局限

  • 证据类型:观察性研究(毒物中心数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 急诊和ICU医生应识别急性大麻暴露的神经毒性表现,儿童意外摄入家庭自制食品后镇静常见,需警惕严重结局。
  • 浓缩产品(树脂和液体浓缩物)暴露,尤其摄入途径,与更高的插管风险相关,儿童暴露后ICU入住和插管可能性更高。
  • 作者认为这些发现可能有助于其他州在早期零售大麻合法化期间制定指导。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: We describe the clinical effects of, and products associated with, acute exposures to cannabis during the early legalization period of recreational cannabis in Oregon and Alaska. Methods: This was an observational study of Oregon/Alaska Poison Center data between 4 December 2015 and 15 April 2017. A standardized data collection instrument was created for this study that captured information about cannabis product description, route of exposure, intentional vs unintentional exposure, product dose, product manufacture source, product ownership source, initial vital signs, clinical signs and symptoms, and subject disposition. Subjects were included if the Poison Center received a call about an acute exposure to cannabis from the subject, subject's family member or friend, or healthcare worker participating in the subject's care. Subjects were excluded if there was no evident exposure, the exposure was chronic, there were co-ingestants, or the subject was non-human (e.g. pet). Results: Two hundred fifty three individuals were acutely exposed to cannabis (median age 20 years; range 8 months - 96 years; 54.2% males): 71 (28.1%) children (<12 years), 42 (16.6%) adolescents (12-17 years), and 140 (55.3%) adults (≥18 years). Children were most likely to unintentionally (98.6%) ingest (97.2%) homemade (35.2%) edibles (64.8%) belonging to a family member (73.2%) and experience sedation (52.1%). Adults were most likely to intentionally (88.6%) ingest (66.4%) retail (40.0%) edibles (48.6%) and experience neuroexcitation (47.1%). Adolescents' exposures had similarities to both adult and children; they were most likely to intentionally (81.0%) ingest (50.0%) homemade (23.8%) edibles (45.2%) belonging to a friend (47.3%) and to experience either neuroexcitation (42.9%) or sedation (40.5%). Among all ages, tachycardia and neuroexcitation were more likely following inhalation exposures compared to ingestions. Eight subjects were admitted to an intensive care unit, including three patients who were intubated; one subject died. Edibles were the most common products to cause symptoms in all age groups, while concentrated products were more likely to lead to intubation, especially when ingested. Children in particular had a higher likelihood of intensive care unit admission and intubation following exposure to concentrated products. Conclusions: Neurotoxicity is common after acute cannabis exposures. Children experienced unintentional exposures, particularly within the home and occasionally with major adverse outcomes. Concentrated products such as resins and liquid concentrates were associated with greater toxicity than other cannabis products. These findings may help guide other states during the early retail cannabis legalization period.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Noble MJ, Hedberg K, Hendrickson RG, et al. Acute cannabis toxicity. Clin Toxicol (Phila). 2019. PMID: 30676820. doi:10.1080/15563650.2018.1548708

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。